Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesTranslocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseasesCB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesModulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the HeartMitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approachesThe protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stressStenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trialsThe role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningRole of the MPTP in conditioning the heart - translatability and mechanismCardioprotection during cardiac surgeryMyocardial reperfusion injury: looking beyond primary PCIIschaemic conditioning: pitfalls on the path to clinical translationHypoxia and ischemia-reperfusion: a BiK contribution?Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS)Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryMetabolic shifts during aging and pathologyEpoxyeicosatrienoic acids and cardioprotection: the road to translationVariations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injuryParacrine mechanisms in adult stem cell signaling and therapyUnique transcriptional profile of sustained ligand-activated preconditioning in pre- and post-ischemic myocardium.Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.Protective effect of picroside II on myocardial ischemia reperfusion injury in ratsSalvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusionCyclosporine A at reperfusion reduces infarct size in pigsMolecular identification for epigallocatechin-3-gallate-mediated antioxidant intervention on the H2O2-induced oxidative stress in H9c2 rat cardiomyoblastsA novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3.Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium.Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.Autophagy induced by ischemic preconditioning is essential for cardioprotection.Morphine induces preconditioning via activation of mitochondrial K(Ca) channelsCardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.Protection of coronary endothelial function during cardiac surgery: potential of targeting endothelial ion channels in cardioprotectionDietary red palm oil supplementation reduces myocardial infarct size in an isolated perfused rat heart model.Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR.Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium.A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction.Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study
P2860
Q24289195-F5943154-6A4E-4F4F-812D-6B5E921AE85FQ24602947-D064A78F-9B92-4914-BD02-5DB1E59637C6Q24649936-F0B41CEF-A584-4319-8423-5A927CE6938CQ26770809-FBDB869D-F39F-4759-86FF-E273B63D390FQ26801561-0E785848-FC5C-4797-93AC-C1BD50571600Q26822734-D3B3A0C8-08AD-4992-8598-8E5C415604A0Q26825240-268598F0-65C7-47D1-A8B5-BD4653684690Q26825733-52EF2E3A-5406-4701-B11C-669020A6CF72Q26830560-F7DDF1B0-999B-402E-8F78-22F5C1CF449AQ26866366-D4E246F6-910D-4ACF-BEB2-DAC8B0F07EFAQ26991482-A0271A86-5ACC-46E2-B740-EDAA99BA23C1Q27000466-508CADB5-64F9-4616-B123-D7E48CC5CE08Q27028077-0B106150-2799-4E36-98C4-2AEAB5605CADQ27318055-2A196E11-42E6-4F4C-AE1F-89CE9499877BQ28072918-AAFADC00-9BBF-45AB-A9BE-9711405923FBQ28088313-8E79405B-3C92-45F4-A901-7A19CBBD00F2Q28241262-13FBE4C9-0F68-4422-ACA2-3C260BB2E0E9Q28583230-007E19A8-2E9A-4004-BDAD-81C3E779AF58Q29620571-B3C77068-D1F2-4C23-B45C-CCA14F8D5081Q31132643-EB06FC72-3CA3-42C5-83A5-7A8467622884Q33639520-47E21B1D-514D-42D4-9620-BD4868CA2E59Q33643575-8E9D0B67-8E93-414E-BCCE-1A9A78BF5AC2Q33645192-4721D230-BC44-4234-8737-94B86ED74519Q33646549-758D43A2-4DAD-4252-B859-533422138498Q33712409-67353545-5077-474E-9487-1BEF4D693869Q33791098-AB466B0A-83F7-4CC8-BF34-3D6708EC1F34Q33805540-F1E607AB-241E-44A4-AE63-DFE6A014DF19Q33825443-5DCAAB52-ECA8-4468-81DF-C6134ECC1A0AQ33895695-30252263-88D8-431C-8330-86364B2A6169Q33957346-5D59A9DA-5ADF-4AF4-87FA-B526F1E4385FQ33970032-49698D56-8BFD-450D-9D9A-D05BD19A934AQ33970045-DF3650B1-A5B8-47A1-9061-496310B0BFD9Q33995071-E09626C7-5C9B-4D8A-A489-01BE8C94DBB6Q34003211-06831CCA-CFBE-4641-B6E3-640AFB2FCEAAQ34004472-F2CCBD6F-07B0-4403-B56A-B3D4B400C7ACQ34010818-15A6D61A-F9F6-4BD0-9BC4-3F6C66FD830EQ34021064-65D46CF5-270C-4209-B59D-21FEA9D278E6Q34100145-C7B3329F-04EC-421B-B04B-A06D62104700Q34121775-5CB9F6B4-87B9-4A6C-B3D4-3ED3CBDF59EEQ34158078-EDB9B0D7-4056-4FE7-B8D8-A3DE073B3A33
P2860
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Interaction of cardiovascular ...... tioning, and postconditioning.
@en
Interaction of cardiovascular ...... tioning, and postconditioning.
@nl
type
label
Interaction of cardiovascular ...... tioning, and postconditioning.
@en
Interaction of cardiovascular ...... tioning, and postconditioning.
@nl
prefLabel
Interaction of cardiovascular ...... tioning, and postconditioning.
@en
Interaction of cardiovascular ...... tioning, and postconditioning.
@nl
P356
P1476
Interaction of cardiovascular ...... itioning, and postconditioning
@en
P2093
Peter Ferdinandy
P304
P356
10.1124/PR.107.06002
P577
2007-11-29T00:00:00Z